Eli Lilly and Company - BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes

Links shared publicly online about this topic.

  • 1,634
    total visits

Eli Lilly and Company - BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes

newsroom.lilly.com

Eli Lilly and Company - BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes

View full resource at newsroom.lilly.com

Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Type 2 Diabetes, Byetta, Eli Lilly and Company

  • Share

Most Recently Shared on November 1, 2009 at 3:10 pm By:

eyeonfda eyeonfda

BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes - http://bit.ly/3SxCxX

3 years ago...

Advertisement